HIV-associated neurocognitive disorders in sub-Saharan Africa: a pilot study in Cameroon

BMC Neurology

Table 3 Laboratory characteristics of the HIV+ group

	Mean CD4 ± SE	P	Mean viral load ± SE	P
	(Cells/μl) [IQR]		(Log copies/ml) [IQR]
HIV+ Non-AIDS (N = 22)	496 ± 51.5		2.86 ± 0.47
	[597.5 - 323]		[4.7 - 0.65]
		0.0005		0.1
HIV+AIDS (N = 22)	251 ± 38.9		4 ± 0.5
	[360.5 - 117]		[5.88 - 1.85]
HIV+ Non-AIDS	493.4 ± 70.5		3.95 ± 0.38	0.0001
No ART (N = 16)	[620 - 268]		[5 - 2.78]
		NS
HIV+ Non-AIDS	502.8 ± 47.6		0.33 ± 0.3
ART (N = 6)	[620.5 - 375]		[0.98 - 0.0]
HIV+AIDS	225.5 ± 42		5.12 ± 0.46
No ART (N = 13)	332.5 - 128]	NS	[6.1 - 4.84]	0.0014
HIV+AIDS	292.5 ± 77.5		2.15 ± 0.67
ART (N = 9)	[471.5 - 109]		[3.65 - 0.65]

SE: standard error; IQR: interquartile range; ART: Antiretroviral therapy; N: sample size; NS: not significant.

ISSN: 1471-2377